STAT-Dx

Our Mission is to Support Timely, Efficient Patient Care, while Optimizing Laboratory and Hospital Processes & Operations. Visit us at

[STAT-Dx @STATDx]

QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing in second half 2018 in Europe and later in the U.S.

[STAT-Dx @STATDx]

STAT-Dx announces CE-IVD mark completion for DiagCORE® System and Respiratory Panel 1

[STAT-Dx @STATDx]

The European Investment Bank is providing STAT-Dx with a EUR 20 million loan facility. https://t.co/zDG8jubsrD

[Business Wire-Health @BW_Health]

Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast 2017-2023: Focus on Product Type, Test Type,… https://t.co/RX7RWZu9At

[STAT-Dx @STATDx]

Hello, world!! Today we are proud to unveil #DiagCORE. There is more than one way to move diagnostics #CloserToCare https://t.co/LDYL4Uw8jR